Evaluation of a BioFire multiplex PCR panel for detection of joint infections using retrospective and prospectively collected specimens

• Published in: Journal of clinical microbiology Vol. 62; no. 8; p. e0018224
• Main Authors: Moran, Angelica, Arellano, Jekzaly, Bregman, Karen, McElvania, Erin
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 14.08.2024
• Subjects: Bacteriology; Clinical Microbiology; multiplex PCR; joint infections; BioFire
• ISSN: 0095-1137; 1098-660X; 1098-660X
• DOI: 10.1128/jcm.00182-24

The BioFire Joint Infection Panel (JI panel) is a newly FDA-approved multiplex PCR assay for detection of common bone and joint pathogens with 39 targets which include select Gram-positive and Gram-negative bacteria, yeast, and antimicrobial resistance genes. We evaluated the performance of the JI panel in detecting joint infections in our patient population. Sixty-three frozen, residual joint fluid specimens were retrospectively tested using the JI panel. An additional 104 residual joint fluid specimens were de-identified and prospectively tested within 1 week of collection. Results from routine bacterial cultures were used as the reference standard, which included inoculation to agar plates and blood culture bottles. For the frozen specimens, the JI panel showed a positive percent agreement (PPA) of 92.8% and a negative percent agreement (NPA) of 97.1%. PPA was 71.4% and NPA was 94.8% for fresh specimens. A total of 12 discrepancies were observed among the 167 specimens tested. The JI panel demonstrated good overall agreement with routine culture for the detection of joint infections and may improve timely diagnosis when used in conjunction with bacterial culture. However, potential false-positive and false-negative results were observed in both retrospective and prospective testing of specimens.IMPORTANCEThe BioFire JI panel is a new commercially available multiplex PCR assay for detecting common pathogens causing bone and joint infections. The test is performed directly on joint fluids with a fast turnaround time of 1 hour. Our study shows that while the JI panel overall shows good agreement with routine culture, discrepancies were observed in 7% of cases and results should be interpreted with appropriate clinical context.